The 26th International Pigment Cell Conference (IPCC 2026) and the 7th Pigmentary Conference take place on April 30th - May 3rd, 2026 At India Habitat Center in New Delhi. This four-day global conference will bring together leading professionals, practitioners, researchers, and health care providers in the field of dermatology, both from India and from countries around the world. For over a decade, the Pigmentary Disorders Society (PDS) has sponsored this event in India for the first time. Approximately 30 international experts and 70 national experts will be participating in the scientific program.

IPCC 2026's Focus Areas

The sessions scheduled include keynote talks, round table discussions, as well as live clinical workshops and demonstrations. There will be an emphasis on serious pigmentary skin disorders such as:

• Vitiligo
• Melasma
• Hyperpigmentation
• Albinism
• All other issues related to the pigmentation of the skin

The overall goal of IPCC 2026 is to provide a venue for knowledge sharing among all areas of dermatology, genetics, medical research, and patient care as well as to share current treatment techniques and to set worldwide clinical standards.

The Need for More Awareness of Pigmentary Disorders

Increasingly medical professionals and the general public are paying attention to pigmentary disorders. This is especially true in India due to gender bias issues, misinformation regarding these disorders, and the continued use of over-the-counter products by patients. Providing accurate diagnoses and evidence-based treatments is now MORE important than ever before.

Dr. Henry Lim, the President of the International League of Dermatological Societies (ILDS), stated that concerns regarding unsafe skin care practices, substances used in many lighting products, and improper use of corticosteroids can have a harmful effect; therefore, improving awareness and clinical safety are critical for the overall improvement of global skin health.

Safe Treatment and Early Diagnosis are a Must According to Experts

Dr. Rashmi Sarkar the President of the Pigmentary Disorders Society and the Organising Chair of IPCC 2026, pointed to the common misconception surrounding pigmentary disorders, which have caused many patients to delay seeking treatment and have negatively impacted their ability to achieve the best possible patient outcome. Dr. Sarkar stated that patients deserve "dignity", "awareness", and "evidence-based care".

According to Dr. Latika Arya, who is a Consultant Dermatologist in New Delhi, it is always safer to seek medical advice from an appropriately certified dermatologist rather than attempting to self-treat or following less than adequately trained individuals’ beauty increase advice. If patients want to achieve optimal results, they will benefit from seeing a licensed specialist who will accurately diagnose their skin issues and tailor the right course of treatment.

According to the Organizing Secretary of the IPCC 2026, Dr Surabhi Sinha, the improper use of topical steroids and skin-lightening products can cause lasting damage to the skin.

Social Implications of Skin Disorders and the Hidden Effects on Society

Dr Amit Kumar Meena, Physician and Consultant at Deen Dayal Upadhyay Hospital, discussed how skin disease and visible pigment problems can lead to social stigma/discrimination that affects how people feel about themselves and subsequently affects how they interact with others and participate in their daily lives.

Also Read: Breathing Techniques for Stress Relief: Simple Ways To Achieve Mental Peace

Through utilizing and leveraging the expert-level contributions of different members of our international panel of experts (faculty), the 2026 Conference in New Delhi will offer new collaborative structures to perform research projects related to developing individual patient pathways and/or standards of care; provide efficient and timely access to evidence-based therapies for patients with pigment-related disorders worldwide; provide opportunities for enhancing clinical practice by establishing quality metrics associated with pigmentary disorders and the safe use of these therapies, etc.